<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmccomplementalternmed&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Complementary and Alternative Medicine - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmccomplementalternmed/</link>
        <description>The latest research articles published by BMC Complementary and Alternative Medicine</description>
        <dc:date>2009-11-21T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/46" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/45" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/44" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/43" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/42" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/41" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/40" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/39" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/38" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/9/37" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/46">
        <title>Cytotoxic and antibacterial activities of endophytic fungi isolated from plants at the National Park, Pahang, Malaysia</title>
        <description>Background:
Endophytes, microorganisms which reside in plant tissues, have potential in producing novel metabolites for exploitation in medicine. Cytotoxic and antibacterial activities of a total of 300 endophytic fungi were investigated.
Methods:
Endophytic fungi were isolated from various parts of 43 plants from the National Park Pahang, Malaysia. Extracts from solid state culture were tested for cytotoxicity against a number of cancer cell lines using the MTT assay.  Antibacterial activity was determined using the disc diffusion method.
Results:
A total of 300 endophytes were isolated from various parts of plants from the National Park, Pahang. 3.3% of extracts showed potent (IC50 &lt; 0.01 ug/ml) cytotoxic activity against the murine leukemic P388 cell line and 1.7% against a human chronic myeloid leukemic cell line K562. Sporothrix sp. (KK29FL1) isolated from Costus speciosus showed strong cytotoxicity against colorectal carcinoma (HCT116) and human breast adenocarcinoma (MCF7) cell lines with IC50 values of 0.05 ug/ml and 0.02 ug/ml, respectively. Antibacterial activity was demonstrated for 8% of the extracts.
Conclusions:
Results indicate the potential for production of bioactive agents from endophytes of the tropical rainforest flora.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/46</link>
                <dc:creator>Nurul Hazalin</dc:creator>
                <dc:creator>Kalavathy Ramasamy</dc:creator>
                <dc:creator>Lim Meng</dc:creator>
                <dc:creator>Ibtisam Abdul Wahab</dc:creator>
                <dc:creator>Anthony Cole</dc:creator>
                <dc:creator>Abu Abdul Majeed</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:46</dc:source>
        <dc:date>2009-11-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-46</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>46</prism:startingPage>
        <prism:publicationDate>2009-11-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/45">
        <title>Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells</title>
        <description>Background:
Vascular endothelial growth factor (VEGF) is a key regulator of pathogenic angiogenesis in diseases such as cancer and diabetic retinopathy.  Bee products [royal jelly (RJ), bee pollen, and Chinese red propolis] from the honeybee, Apis mellifera, have been used as traditional health foods for centuries.  The aim of this study was to investigate the anti-angiogenic effects of bee products using human umbilical vein endothelial cells (HUVECs).
Methods:
In an in vitro tube formation assay, HUVECs and fibroblast cells were incubated for 14 days with VEGF and various concentrations of bee products [RJ, ethanol extract of bee pollen, ethanol extract of Chinese red propolis and its constituent, caffeic acid phenethyl ester (CAPE)].  To clarify the mechanism of in vitro angiogenesis, HUVEC proliferation and migration were induced by VEGF with or without various concentrations of RJ, bee pollen, Chinese red propolis, and CAPE.
Results:
RJ, bee pollen, Chinese red propolis, and CAPE significantly suppressed VEGF-induced in vitro tube formation in the descending order: CAPE &gt; Chinese red propolis &gt;&gt; bee pollen &gt; RJ.  RJ and Chinese red propolis suppressed both VEGF-induced HUVEC proliferation and migration.  In contrast, bee pollen and CAPE suppressed only the proliferation.
Conclusions:
Among the bee products, Chinese red propolis and CAPE in particular showed strong suppressive effects against VEGF-induced angiogenesis.  These findings indicate that Chinese red propolis and CAPE may have potential as preventive and therapeutic agents against angiogenesis-related human diseases.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/45</link>
                <dc:creator>Hiroshi Izuta</dc:creator>
                <dc:creator>Masamitsu Shimazawa</dc:creator>
                <dc:creator>Kazuhiro Tsuruma</dc:creator>
                <dc:creator>Yoko Araki</dc:creator>
                <dc:creator>Satoshi Mishima</dc:creator>
                <dc:creator>Hideaki Hara</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:45</dc:source>
        <dc:date>2009-11-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-45</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>45</prism:startingPage>
        <prism:publicationDate>2009-11-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/44">
        <title>Interleukin-6 and Cyclooxygenase-2 downregulation by fatty-acid fractions of Ranunculus constantinopolitanus</title>
        <description>Background:
Medicinal plants represent alternative means for the treatment of several chronic diseases, including inflammation. The genus Ranunculus, a representative of the Ranunculaceae family, has been reported to possess anti-inflammatory, analgesic, antiviral, antibacterial, antiparasitic and antifungal activities, possibly due to the presence of anemonin and other. Different studies have shown the occurrence of unusual fatty acids (FAs) in Ranunculaceae; however, their therapeutic role has not been investigated. The purpose of this study is to characterize potential anti-inflammatory bioactivities in Ranunculus constantinopolitanus D&apos;Urv., traditionally used in Eastern Mediterranean folk medicine.
Methods:
The aerial part of R. constantinopolitanus was subjected to methanol (MeOH) extraction and solvent fractionation. The bioactive fraction (I.2) was further fractionated using column chromatography, and the biologically active subfraction (Y2+3) was identified using infrared (IR) spectroscopy, nuclear magnetic resonance (NMR) and gas chromatorgraphy-mass spectrometry (GC-MS). The effects of I.2 and Y2+3 on cell viability were studied in mouse mammary epithelial SCp2 cells using trypan blue exclusion method. To study the anti-inflammatory activities of I.2 and Y2+3, their ability to reduce interleukin (IL)-6 levels was assessed in endotoxin (ET)-stimulated SCp2 cells using enzyme-linked immunosorbent assay (ELISA). In addition, the ability of Y2+3 to reduce cyclooxygenase (COX)-2 expression was studied in IL-1-treated mouse intestinal epithelial Mode-K cells via western blotting. Data were analyzed by one-way analysis of variance (ANOVA), Student-Newman-Keuls (SNK), Tukey HSD, two-sample t-test and Dunnett t-tests for multiple comparisons.
Results:
The chloroform fraction (I.2) derived from crude MeOH extract of the plant, in addition to Y2+3, a FA mix isolated from this fraction and containing palmitic acid, C18:2 and C18:1 isomers and stearic acid (1:5:8:1 ratio), reduced ET-induced IL-6 levels in SCp2 cells without affecting cell viability or morphology. When compared to fish oil, conjugated linoleic acid (CLA) and to individual FAs as palmitic, linoleic, oleic and stearic acid or to a mix of these FAs (1:5:8:1 ratio), Y2+3 exhibited higher potency in reducing ET-induced IL-6 levels within a shorter period of time. Y2+3 also reduced COX-2 expression in IL-1-treated Mode-K cells.
Conclusions:
Our studies demonstrate the existence of potential anti-inflammatory bioactivities in R. constantinopolitanus and attribute them to a FA mix in this plant.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/44</link>
                <dc:creator>Sabreen Fostok</dc:creator>
                <dc:creator>Rima Ezzeddine</dc:creator>
                <dc:creator>Fadia Homaidan</dc:creator>
                <dc:creator>Jamal Al-Saghir</dc:creator>
                <dc:creator>Ralph Salloum</dc:creator>
                <dc:creator>Najat Saliba</dc:creator>
                <dc:creator>Rabih Talhouk</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:44</dc:source>
        <dc:date>2009-11-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-44</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>44</prism:startingPage>
        <prism:publicationDate>2009-11-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/43">
        <title>Mutagenicity of Chinese traditional medicine Semen Armeniacae amarum by two modified Ames tests</title>
        <description>Background:
Semen armeniacae amarum (SAA) is a Chinese traditional medicine and has long been used to control acute lower respiratory tract infection and asthma, as a result of its expectorant and antiasthmatic activities. However, its mutagenicity in vitro and in vivo has not yet been reported. The Ames test for mutagenicity is used worldwide. The histidine contained in biological samples can induce histidine-deficient cells to replicate, which results in more his+ colonies than in negative control cells, therefore false-positive results may be obtained. So, it becomes a prerequisite to exclude the effects of any residual histidine from samples when they are assayed for their mutagenicity. Chinese traditional herbs, such as SAA, are histidine-containing biological sample, need modified Ames tests to assay their in vitro mutagenicity.
Methods:
The mutagenicity of SAA was evaluated by the standard and two modified Ames tests. The first modification used the plate incorporation test same as standard Ames teat, but with new negative control systems, in which different amounts of histidine corresponding to different concentrations of SAA was incorporated. When the number of his+ revertants in SAA experiments was compared with that in new negative control, the effect of histidine contained in SAA could be eliminated. The second modification used a liquid suspension test similar to the standard Ames test, except with histidine-rich instead of histidine-limited medium. The aim of this change was to conceal the effect of histidine contained in SAA on the final counting of his+ revertants, and therefore to exclude false-positive results of SAA in the Ames test. Furthermore, the effect of SAA on chromosomal aberration in mammalian bone marrow cells was tested.
Results:
The standard Ames test showed a positive result for mutagenicity of SAA. In contrast, a negative response was obtained with the modified plate incorporation and modified suspension Ames tests. Moreover, no apparent chromosomal aberrations were observed in mammalian bone marrow cells treated with SAA.
Conclusion:
The standard Ames test was not suitable for evaluating the mutagenicity of SAA, because false-positive result could be resulted by the histidine content in SAA. However, the two modified Ames tests were suitable, because the experimental results proved that the effect of histidine in SAA and therefore the false-positive result were effectively excluded in these two modified Ames tests. This conclusion needs more experimental data to support in the future. Moreover, the experimental results illustrated that SAA had no mutagenicity in vitro and in vivo. This was in agreement with the clinical safety of SAA long-term used in China.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/43</link>
                <dc:creator>Jianling Jin</dc:creator>
                <dc:creator>Bo Liu</dc:creator>
                <dc:creator>Hui Zhang</dc:creator>
                <dc:creator>Xiao Tian</dc:creator>
                <dc:creator>Yupin Cai</dc:creator>
                <dc:creator>Peiji Gao</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:43</dc:source>
        <dc:date>2009-11-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-43</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>43</prism:startingPage>
        <prism:publicationDate>2009-11-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/42">
        <title>Self-medication with over-the-counter drugs and complementary medications in South Australia&apos;s elderly population</title>
        <description>Background:
A number of surveys have examined use of complementary and alternative medicines (CAM) in Australia. However, there are limited Australian data on use of CAM and over-the-counter (OTC) medicines in the elderly population. The main aims of this study were to examine self-medication practices with CAM and OTC medicines among older Australians and variables associated with their use.
Methods:
The Australian Longitudinal Study of Ageing (ALSA) is an ongoing multidisciplinary prospective study of the older population which commenced in 1992 in South Australia. Data collected in 4 waves of ALSA between 1992 and 2004 were used in this study with a baseline sample of 2087 adults aged 65 years and over, living in the community or residential aged care. OTC medicines were classified according to the World Health Organization Anatomical Therapeutic Chemical (ATC) classification. CAM were classified according a modified version of the classification adopted by the Therapeutics Goods Administration (TGA) in Australia.
Results:
The prevalence of CAM or OTC use ranged from 17.7% in 2000-2001 to 35.5% in 2003-2004. The top classes of CAM and OTC medicines used remained relatively constant over the study period. The most frequent classes of CAM used were vitamins and minerals, herbal medicines and nutritional supplements while the most commonly used OTC were analgesics, laxatives and low dose aspirin. Females and those of younger age were more likely to be CAM users but no variable was associated with OTC use.
Conclusion:
Participants seemed to self-medicate in accordance with approved indications, suggesting they were informed consumers, actively looking after their own health. However, use of analgesics and aspirin are associated with an increased risk of adverse drug events in the elderly. Future work should examine how self-medication contributes to polypharmacy and increases the risk of adverse drug reactions.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/42</link>
                <dc:creator>Lynn Yeen Goh</dc:creator>
                <dc:creator>Agnes Vitry</dc:creator>
                <dc:creator>Susan Semple</dc:creator>
                <dc:creator>Adrian Esterman</dc:creator>
                <dc:creator>Mary Luszcz</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:42</dc:source>
        <dc:date>2009-11-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-42</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>42</prism:startingPage>
        <prism:publicationDate>2009-11-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/41">
        <title>Use of complementary and alternative medicine: a survey in Turkish gastroenterology patients.</title>
        <description>Background:
The study examined complementary and alternative medicine (CAM) usage by patients attending a Turkish gastroenterology outpatient clinic.
Methods:
The survey was conducted on 216 patients presenting with gastrointestinal problems during their first visit to the clinic using a 31 item, self-report questionnaire between May and October 2005. Data included information on patient demographics and their gastrointestinal symptoms, as well as items to identify CAM use and patient satisfaction with these therapies.
Results:
Seventy-nine patients (36.6%) reported using one or more forms of CAM. The most commonly used therapy was herbal therapy, usually taken as a tea or infusion. These were used by 27 people (29%) in this subgroup. Common indicators for their use were epigastric pain, constipation, bloating and dyspepsia or indigestion. CAM use among upper GI patients was marginally higher than lower GI patients (41.8% versus 41.2%), but the highest usage was amongst patients with liver disease where 53.8% reported using one or more CAM therapy. About half of the patients learned about CAM from their relatives or friends, with more women than men using the therapies (p &lt; 0.05). Clinical characteristics such as diagnosis, duration of symptoms and prior surgical intervention did not differ between users and non-users of CAM therapies. Multivariate analysis showed that being female and higher educational status were positively associated with CAM usage (p &lt; 0.05).
Conclusion:
CAM usage in our sample of gastrointestinal patients was lower than that described in other countries and other chronic disease groups. This could be due to their low perceived efficacy, or the relatively transient duration of symptoms experienced by the sample. Healthcare professionals need however, to be aware of CAM usage in order to educate patients appropriately about possible adverse effects or drug-interactions.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/41</link>
                <dc:creator>Taylan Kav</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:41</dc:source>
        <dc:date>2009-10-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-41</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>41</prism:startingPage>
        <prism:publicationDate>2009-10-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/40">
        <title>Traditional eye medicine use by newly presenting ophthalmic patients to a teaching hospital in South-eastern Nigeria: socio-demographic and clinical correlates</title>
        <description>Background:
This study set out to determine the incidence, socio-demographic, and clinical correlates of Traditional Eye Medicine (TEM) use in a population of newly presenting ophthalmic outpatients attending a tertiary eye care centre in south-eastern Nigeria.
Methods:
In a comparative cross-sectional survey at the eye clinic of the University of Nigeria Teaching Hospital (UNTH), Enugu, between August 2004 - July 2006, all newly presenting ophthalmic outpatients were recruited. Participants&apos; socio-demographic and clinical data and profile of TEM use were obtained from history and examination of each participant and entered into a pretested questionnaire and proforma. Participants were subsequently categorized into TEM- users and non-users; intra-group analysis yielded proportions, frequencies, and percentages while chi-square test was used for inter-group comparisons at P = 0.01, df = 1.
Results:
Of the 2,542 (males, 48.1%; females, 51.9%) participants, 149 (5.9%) (males, 45%; females, 55%) used TEM for their current eye disease. The TEMs used were chemical substances (57.7%), plant products (37.7%), and animal products (4.7%). They were more often prescribed by non-traditional (66.4%) than traditional (36.9%) medicine practitioners. TEMs were used on account of vision loss (58.5%), ocular itching (25.4%) and eye discharge (3.8%). Reported efficacy from previous users (67.1%) and belief in potency (28.2%) were the main reasons for using TEM. Civil servants (20.1%), farmers (17.7%), and traders (14.1%) were the leading users of TEM. TEM use was significantly associated with younger age (p &lt; 0.01), being married (p &lt; 0.01), rural residence (p &lt; 0.01), ocular anterior segment disease (p &lt; 0.01), delayed presentation (p &lt; 0.01), low presenting visual acuity (p &lt; 0.01), and co-morbid chronic medical disease (p &lt; 0.01), but not with gender (p = 0.157), and educational status (p = 0.115).
Conclusion:
The incidence of TEM use among new ophthalmic outpatients at UNTH is low. The reasons for TEM use are amenable to positive change through enhanced delivery of promotive, preventive, and curative public eye care services. This has implications for eye care planners and implementers. To reverse the trend, we suggest strengthening of eye care programmes, even distribution of eye care resources, active collaboration with orthodox eye care providers and traditional medical practitioners, and intensification of research efforts into the pharmacology of TEMs.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/40</link>
                <dc:creator>Boniface Eze</dc:creator>
                <dc:creator>Chimdi Chuka-Okosa</dc:creator>
                <dc:creator>Judith Uche</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:40</dc:source>
        <dc:date>2009-10-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-40</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>40</prism:startingPage>
        <prism:publicationDate>2009-10-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/39">
        <title>Dietary supplementation by older adults in southern China: a hospital outpatient clinic study</title>
        <description>Background:
There has been little knowledge about dietary supplementation by the Chinese elderly. The aim of this cross-sectional study was to investigate the usage of dietary supplements by older adults in southern China.
Methods:
A total of 600 community-dwelling older adults were recruited from the outpatient clinics of three major hospitals in Foshan city between July 2007 and July 2008. Face-to-face interviews of participants were conducted to obtain information on demographics, lifestyle and dietary supplements use. Frequency and duration of usage were recorded for six categories of dietary supplements.
Results:
Among the 446 consented participants (241 men and 205 women) who were over 55 years of age, 19.1% consumed one or more types of dietary supplements. The prevalence of usage was significantly higher (p = 0.008) for females (24.4%) than for males (14.5%). Dietary supplements were more likely to be consumed by non-smokers (p = 0.021) and those with hyperlipidemia (p = 0.003). The most popular supplement among users was calcium (53%). The majority (71%) of the users consumed supplements on a regular basis at one or more times per day, with an average duration of 2.95 (SD 4.80) years.
Conclusion:
The overall prevalence of dietary supplementation in this older Chinese population was considerably lower than those in other Asia-Pacific countries.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/39</link>
                <dc:creator>Wenbin Liang</dc:creator>
                <dc:creator>Andy Lee</dc:creator>
                <dc:creator>Colin Binns</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:39</dc:source>
        <dc:date>2009-10-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-39</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>39</prism:startingPage>
        <prism:publicationDate>2009-10-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/38">
        <title>Evaluation and implications of natural product use in preoperative patients:  a retrospective review</title>
        <description>Background:
Medication Reconciliation and Medication Safety are two themes emphasized in a variety of healthcare organizations. As a result, health care facilities have established methods for obtaining a patient&apos;s medication history. However, these methods may vary among institutions or even among the health care professionals in a single institution, and studies have shown that patients are reluctant to disclose their complementary and alternative medicine use to any health care professional. This lack of disclosure is important in surgical patients because of potential herbal interactions with medications and drugs used during the surgical procedure; and the potential for adverse reactions including effects on coagulation, blood pressure, sedation, electrolytes or diuresis. Therefore, the objectives of this study are to identify patterns of natural product use, to identify potential complications among patients scheduled for surgery, to improve existing medication reconciliation efforts, and to develop discontinuation guidelines for the use of these products prior to surgery.
Methods:
A retrospective review of surgery patients presenting to the Anesthesia Preoperative Evaluation Clinic (APEC) at the University of Kansas Hospital was conducted to identify the prevalence of natural product use. The following data was collected: patient age; gender; allergy information; date of medication history; number of days prior to surgery; source of medication history; credentials of person obtaining the history; number and name of prescription medications, over-the-counter medications and natural products; and natural product dosage. Following the collection of data and analysis of the most common natural products used, possible complications and interactions were identified, and a protocol regarding the pre-operative use of natural products was developed and implemented.
Results:
Approximately one-fourth of patients seen in the APEC indicated the use of natural products. Patients taking natural products were significantly older, were more likely to undergo cardiac or chest surgery, and were more likely to be taking more prescription and non-prescription medications (all p &lt; 0.001).
Conclusion:
Based on the results of this study, it is concluded that there is a need for established guidelines regarding discontinuation of selected natural products prior to surgery and further education is needed concerning the perioperative implications of natural products.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/38</link>
                <dc:creator>Allison King</dc:creator>
                <dc:creator>Flint Russett</dc:creator>
                <dc:creator>Joyce Generali</dc:creator>
                <dc:creator>Dennis Grauer</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:38</dc:source>
        <dc:date>2009-10-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-38</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>38</prism:startingPage>
        <prism:publicationDate>2009-10-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/9/37">
        <title>Justification for the use of Ocimum gratissimum L in herbal medicine and its interaction with disc antibiotics. </title>
        <description>Background:
The ethanolic extract of the leaves of Ocimium gratisimum L. (Lamiaceae), used in traditional medicine for the treatment of several ailments such as urinary tract, wound, skin and gastrointestinal infections, was evaluated for its antibacterial properties against four clinical bacteria isolates namely: Escherichia coli, Proteus mirabilis, Staphylococcus aureus and Pseudomonas aeruginosa and the antifungal properties using a clinical isolate of Candida albicans. A typed bacterium of Escherichia coli ATCC 11775 and another typed fungal strain of Candida albicans (ATCC 90028) were also included. The study also intended to verify if the concomitant administration of conventional antibiotics with Ocimium gratisimum which is normally taken as food (spice) will negatively affect its activity.
Methods:
The agar diffusion method was used to test the in vitro activity of the plant extract. The interaction of the plant extract with some disc antibiotics namely: ciprofloxacin, septrin, streptomycin, ampicillin, nystatin and ketoconazole was tested using the agar overlay inoculum susceptibility disc method. Phytochemical analysis of the extract was performed following established methods.
Results:
The extract showed good but varying in vitro activities against all the isolates tested. While ampicillin showed synergistic interaction with the plant extract against clinical isolates of E. coli and P. mirabilis, septrin was synergistic against the clinical isolate of E. coli only. Similarly, the activity of the extract against C. albicans isolate was synergistic with ketoconazole and nystatin.
Conclusion:
The study has validated the folkloric use of O. gratissimum in traditional medicinal practice and goes further to show that the use of this plant material as food spice may not really threaten the efficacy of some conventional antibiotics that may have been taken concomitantly with it as is the popular belief in the practice of herbal medicine in local/rural communities of many countries in the world.</description>
        <link>http://www.biomedcentral.com/1472-6882/9/37</link>
                <dc:creator>Emeka Nweze</dc:creator>
                <dc:creator>Elizabeth Eze</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2009, 9:37</dc:source>
        <dc:date>2009-09-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-9-37</dc:identifier>
        <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>37</prism:startingPage>
        <prism:publicationDate>2009-09-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
